Patents by Inventor James Blinn

James Blinn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070121132
    Abstract: Techniques relating to spectral color management are described. In one example, a process receives spectral color data associated with a physical color response. In this example the process also processes the spectral color data into device data suitable for a target device while maintaining an ability to replicate the physical color response from the device data.
    Type: Application
    Filed: November 30, 2005
    Publication date: May 31, 2007
    Applicant: Microsoft Corporation
    Inventors: James Blinn, Charles Mauzy, Gary Starkweather, J. Whitted, Michael Stokes
  • Publication number: 20070097123
    Abstract: A shape defined partially be a Bezier curve is rendered through a GPU-implemented technique which determines for various screen points which side of the curve the points lie on. This is done in the particular case of cubic Bezier curves for shapes defined by the Bézier control points of the curves. The type of the curve is identified through an analysis of an inflection point polynomial based on the curve. The curve is then projected to a canonical implicit form in a canonical texture space, allowing computation to be efficiently performed on a simple canonical form of the curve.
    Type: Application
    Filed: October 31, 2005
    Publication date: May 3, 2007
    Applicant: Microsoft Corporation
    Inventors: Charles Loop, James Blinn
  • Publication number: 20070097121
    Abstract: Surfaces defined by a Bézier tetrahedron, and in particular quadric surfaces, are rendered on programmable graphics hardware. Pixels are rendered through triangular sides of the tetrahedra and locations on the shapes, as well as surface normals for lighting evaluations, are computed using pixel shader computations. Additionally, vertex shaders are used to aid interpolation over a small number of values as input to the pixel shaders. Through this, rendering of the surfaces is performed independently of viewing resolution, allowing for advanced level-of-detail management. By individually rendering tetrahedrally-defined surfaces which together form complex shapes, the complex shapes can be rendered in their entirety.
    Type: Application
    Filed: October 27, 2005
    Publication date: May 3, 2007
    Applicant: Microsoft Corporation
    Inventors: Charles Loop, James Blinn
  • Publication number: 20050238228
    Abstract: Image data processing and image rendering methods and systems whereby images are displayed on display devices having pixels with separately controllable pixel sub-components. Image data, such as data encoded in a three-channel signal, is passed through a low-pass filter to remove frequencies higher than a selected cutoff frequency, which obtain samples from the color components of the signal that map spatially different image regions to individual pixel sub-components. It has been found that color aliasing effects can be significantly reduces at a cutoff frequency somewhat higher than the Nyquist frequency, while enhancing the spatial resolution of the image. The image data is then passed through sampling filters, A generalized set of filters includes nine filters, one for each combination of one color and one pixel sub-component.
    Type: Application
    Filed: June 24, 2005
    Publication date: October 27, 2005
    Applicant: Microsoft Corporation
    Inventors: John Platt, Donald Mitchell, J. Whitted, James Blinn
  • Patent number: 6685617
    Abstract: The present invention relates to compound of formula (I), that are potent inhibitors of &agr;4&bgr;1 mediated adhesion to either VCAM or CS-1 and which could be useful for the treatment of inflammatory diseases. Specifically, the molecules of the present invention can be used for treating or preventing &agr;4&bgr;1 adhesion mediated conditions in a mammal such as a human. This method may comprise administering to a mammal or a human patient an effective amount of the compound or composition as explained in the present specification.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: February 3, 2004
    Assignees: Pharmacia & Upjohn Company, Tanabe Seiyaku Co., Ltd.
    Inventors: James Blinn, Robert Chrusciel, Jed Fisher, Steven Tanis, Edward Thomas, Thomas Lobl, Bradley Teegarden